Enrolling by invitationNCT03862274
Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease
Studying Batten Disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jessica Scherr
- Principal Investigator
- Jessica Scherr, PhDNationwide Children's Hospital
- Intervention
- CLN2 Treatment(other)
- Enrollment
- 30 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2025
Study locations (1)
- Nationwide Children's Hospital, Columbus, Ohio, United States
Collaborators
BioMarin Pharmaceutical
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03862274 on ClinicalTrials.govOther trials for Batten Disease
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05228145Gene Therapy Study for Children With CLN5 Batten DiseaseNeurogene Inc.
- ACTIVE NOT RECRUITINGNCT04273243Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene TransferEmily de los Reyes
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03770572Gene Therapy for Children With CLN3 Batten DiseaseAlcyone Therapeutics, Inc
- ACTIVE NOT RECRUITINGNCT03285425Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 DiseaeEmily de los Reyes
- RECRUITINGNCT01873924Clinical and Neuropsychological Investigations in Batten DiseaseUniversity of Rochester